Impact of menopausal hormone therapy, breast tumor characteristics, and treatment on overall survival of 3813 breast cancer patients (The Marieplus study)

Nadia Obi, Judit Heinz, Alina Vrieling, Jenny Chang-Claude & Dieter Flesch-Janys
Introduction: Menopausal hormone therapy (HT) is a well established risk factor for developing breast cancer. However, the impact of pre-diagnostic HT use on overall mortality is controversial. The majority of observational studies found a reduced breast cancer mortality, while in the follow-up of the[for full text, please go to the a.m. URL]